Last reviewed · How we verify
QLM2010 for injection；dexamethasone
Dexamethasone is a corticosteroid that suppresses the immune system and reduces inflammation.
Dexamethasone is a corticosteroid that suppresses the immune system and reduces inflammation. Used for Multiple myeloma, Hodgkin lymphoma, Non-Hodgkin lymphoma.
At a glance
| Generic name | QLM2010 for injection；dexamethasone |
|---|---|
| Sponsor | Qilu Pharmaceutical Co., Ltd. |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
Dexamethasone works by inhibiting the production of inflammatory cytokines and mediators, which are molecules that promote inflammation. This leads to a decrease in the severity of symptoms associated with inflammation and immune system disorders.
Approved indications
- Multiple myeloma
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
Common side effects
- Nausea
- Vomiting
- Headache
- Dizziness
- Insomnia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: